Considerations on equity in management of end-stage kidney disease in low- and middle-income countries.
end-stage kidney disease
equity
ethical framework
kidney replacement therapy
reimbursement
social justice
Journal
Kidney international supplements
ISSN: 2157-1724
Titre abrégé: Kidney Int Suppl (2011)
Pays: United States
ID NLM: 101562008
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
26
06
2019
revised:
11
10
2019
accepted:
07
11
2019
entrez:
10
3
2020
pubmed:
10
3
2020
medline:
10
3
2020
Statut:
ppublish
Résumé
Achievement of equity in health requires development of a health system in which everyone has a fair opportunity to attain their full health potential. The current, large country-level variation in the reported incidence and prevalence of treated end-stage kidney disease indicates the existence of system-level inequities. Equitable implementation of kidney replacement therapy (KRT) programs must address issues of availability, affordability, and acceptability. The major structural factors that impact equity in KRT in different countries are the organization of health systems, overall health care spending, funding and delivery models, and nature of KRT prioritization (transplantation, hemodialysis or peritoneal dialysis, and conservative care). Implementation of KRT programs has the potential to exacerbate inequity unless equity is deliberately addressed. In this review, we summarize discussions on equitable provision of KRT in low- and middle-income countries and suggest areas for future research.
Identifiants
pubmed: 32149010
doi: 10.1016/j.kisu.2019.11.004
pii: S2157-1716(19)30018-8
pmc: PMC7031686
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e63-e71Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Références
Clin J Am Soc Nephrol. 2019 Apr 5;14(4):491-492
pubmed: 30898874
Lancet. 2012 Mar 17;379(9820):e36-8
pubmed: 22405254
Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8
pubmed: 28236831
Lancet Glob Health. 2017 Sep;5(9):e875-e887
pubmed: 28728918
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):74-77
pubmed: 27469149
Kidney Int. 2018 Sep;94(3):440-445
pubmed: 30143062
Lancet Glob Health. 2017 Apr;5(4):e408-e417
pubmed: 28229924
Perit Dial Int. 2001;21 Suppl 3:S314-7
pubmed: 11887843
Kidney Int Rep. 2018 Jul 27;3(5):1027-1029
pubmed: 30197968
Semin Nephrol. 2017 May;37(3):273-286
pubmed: 28532556
Kidney Int. 2011 Dec;80(12):1258-70
pubmed: 21993585
Med J Islam Repub Iran. 2017 Aug 27;31:47
pubmed: 29445676
Clin Kidney J. 2018 Oct;11(5):726-733
pubmed: 30288270
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):61-63
pubmed: 27469161
Bull World Health Organ. 2018 Jul 1;96(7):442
pubmed: 29962543
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):23-26
pubmed: 27469146
Health Policy Plan. 2012 Mar;27 Suppl 1:i4-12
pubmed: 22388499
Clin J Am Soc Nephrol. 2019 Apr 5;14(4):523-529
pubmed: 30898873
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):29-33
pubmed: 27509582
Kidney Int Rep. 2018 Dec 20;4(3):390-398
pubmed: 30899866
Kidney Int Suppl (2011). 2016 Dec;6(2):42-51
pubmed: 30675419
Lancet. 2006 Oct 28;368(9546):1524-34
pubmed: 17071286
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):64-68
pubmed: 27469148
Kidney Int. 2016 Dec;90(6):1164-1174
pubmed: 27884311
BMJ. 2013 Jan 31;346:f462
pubmed: 23369775
Kidney Int. 2006 Sep;70(6):1107-14
pubmed: 16883316
Kidney Int. 2019 Apr;95(4S):S1-S33
pubmed: 30904051
Clin J Am Soc Nephrol. 2019 Jan 7;14(1):84-93
pubmed: 30545819
Perit Dial Int. 2007 Mar-Apr;27(2):142-8
pubmed: 17299147
Clin J Am Soc Nephrol. 2010 Apr;5(4):637-44
pubmed: 20167688
Int J Med Inform. 2019 May;125:47-54
pubmed: 30914180
Clin Nephrol. 2016 Supplement 1;86 (2016)(13):78-83
pubmed: 27879188
Semin Nephrol. 2017 May;37(3):287-295
pubmed: 28532557
Bull World Health Organ. 2014 Jun 1;92(6):389
pubmed: 24940009
PLoS One. 2016 Oct 4;11(10):e0164201
pubmed: 27701466
Rev Med Inst Mex Seguro Soc. 2016 Sep-Oct;54(5):588-93
pubmed: 27428340
Dev World Bioeth. 2015 Dec;15(3):233-40
pubmed: 24953161
BMC Nephrol. 2018 Feb 2;19(1):28
pubmed: 29394930